Inqovi® (decitabine and cedazuridine)
for Leukemia

Inqovi (decitabine and cedazuridine) is used to treat adults with myelodysplastic syndromes (MDS), including chronic myelomonocytic leukemia (CMML), conditions where bone marrow doesn't make enough healthy blood cells. Decitabine promotes normal blood cell production and slows abnormal cell growth, while cedazuridine prevents decitabine breakdown, enhancing its effectiveness.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Leukemia